RecruitingNot ApplicableNCT06971627

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease


Sponsor

Istanbul University - Cerrahpasa

Enrollment

120 participants

Start Date

Apr 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether regular check-ins and support through telehealth (video calls and messaging apps) can help people with inflammatory bowel disease (IBD) — like Crohn's disease or ulcerative colitis — take their medications more consistently and feel better about managing their condition. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with IBD for at least 6 months - Your IBD is currently in remission (symptoms are well controlled) - You can read and write in Turkish - You own a smartphone with access to a messaging app (e.g., WhatsApp) and email - You are able to use a video calling app like Zoom **You may NOT be eligible if...** - You have a psychiatric or cognitive disorder - You have a condition that makes communication difficult - You are pregnant - You receive infusion-based treatments - You have a serious chronic illness beyond IBD Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALNurse-led Telehealth Monitoring Program

Participants in the intervention group will be included in a structured telehealth monitoring program led by a nurse for 12 weeks.

OTHERNo intervention

Participants in the control group will only receive standard care. No additional interventions will be implemented during the 12-week period.


Locations(1)

Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06971627


Related Trials